Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic pyrazole-carboxamidesas P2Y12 antagonists

Heterocyclic pyrazole-carboxamidesas P2Y12 antagonists

US Patent 8426420 · Granted Apr 23, 2013

Estimated economic value: $58,524,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic compounds as class II phosphoinositide 3-kinase inhibitors2025
Multispecific binding proteins with mutant fab domains2024
1,2,4-triazole derivatives as tankyrase inhibitors2024
Isoxazolidines as RIPK1 inhibitors and use thereof2024
PseudoFab-based multispecific binding proteins2023
Selective inhibitors of gentotoxic steress-induced IKK/NF-κB pathways2021
Xanthine derivatives, their use as a medicament, and pharmaceutical preparations2021
Xanthine derivatives, their use as a medicament, and pharmaceutical preparations2020
Antagonists of the thyroid-stimulating hormone receptor (TSHR)2020
Xanthine derivatives, their use as a medicament, and pharmaceutical preparations2019
Fused pyrroledicarboxamides and their use as pharmaceuticals2018
N-(4-(azaindazol-6-yl)-phenyl)-sulfonamides and their use as pharmaceuticals2017